Evidence map›Paper›PMID 32815519›Full record

ArticleDiagnostic and interventional radiology (Ankara, Turkey)2021

Determination of disease severity in COVID-19 patients using deep learning in chest X-ray images.

Maxime Blain, Michael T Kassin, Nicole Varble, Xiaosong Wang, Ziyue Xu, Daguang Xu, Gianpaolo Carrafiello, Valentina Vespro, Elvira Stellato, Anna Maria Ierardi and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Diagnostic and interventional radiology (Ankara, Turkey), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review.Archives of computational methods in engineering : state of the art reviews · 2023
    Review
  10. Article
  11. Review
  12. COVID-19 pneumonia: lessons learned, challenges, and preparing for the future.Diagnostic and interventional radiology (Ankara, Turkey) · 2022
    Article
  13. AI for COVID-19 Detection from Radiographs: Incisive Analysis of State of the Art Techniques, Key Challenges and Future Directions.Ingenierie et recherche biomedicale : IRBM = Biomedical engineering and research · 2022
    Review
  14. An Unsupervised Fuzzy Clustering Approach for Early Screening of COVID-19 From Radiological Images.IEEE transactions on fuzzy systems : a publication of the IEEE Neural Networks Council · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Deep GRU-CNN Model for COVID-19 Detection From Chest X-Rays Data.IEEE access : practical innovations, open solutions · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Maxime BlainCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA.
Michael T KassinCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA.
Nicole VarblePhilips Research North America, Cambridge, Massachusetts, USA.
Xiaosong WangNVIDIA Corporation, Bethesda, Maryland, USA.
Ziyue XuNVIDIA Corporation, Bethesda, Maryland, USA.
Daguang XuCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA.
Gianpaolo CarrafielloDepartment of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Valentina VesproDepartment of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Elvira StellatoDepartment of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Anna Maria IerardiDepartment of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Letizia Di MeglioDepartment of Radiology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Robert D SuhDepartment of Radiology, University of California Los Angeles, Los Angeles, California, USA.
Stephanie A WalkerNational Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Sheng XuCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA.
Thomas H SanfordCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA;State University of New York Upstate Medical University, Syracuse, Newyork, USA.
Evrim B TurkbeyMolecular Imaging Program, National Institutes of Health, Bethesda, Maryland, USA;Department of Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Mayland, USA.
Stephanie HarmonNational Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Baris TurkbeyDepartment of Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Mayland, USA.
Bradford J WoodCenter for Interventional Oncology, National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland, USA;Department of Radiology, University of California Los Angeles, Los Angeles, California, USA;Department of Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Mayland, USA.
Nvidia (United States) · USNational Cancer Institute · USPhilips (United States) · USUniversity of California, Los Angeles · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
Center for Interventional OncologyZIDBC011242 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2009 to 2025
$18.7M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Development of COVID-19 Imaging Tools with Artificial IntelligenceZIABC011936 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2020 to 2025
$1.2M
Intramural NIH HHS ZID BC011242NCI NIH HHS 75N91019D00024
6 · The paper itself

Abstract

purposeChest X-ray plays a key role in diagnosis and management of COVID-19 patients and imaging features associated with clinical elements may assist with the development or validation of automated image analysis tools. We aimed to identify associations between clinical and radiographic features as well as to assess the feasibility of deep learning applied to chest X-rays in the setting of an acute COVID-19 outbreak.

methodsA retrospective study of X-rays, clinical, and laboratory data was performed from 48 SARS-CoV-2 RT-PCR positive patients (age 60±17 years, 15 women) between February 22 and March 6, 2020 from a tertiary care hospital in Milan, Italy. Sixty-five chest X-rays were reviewed by two radiologists for alveolar and interstitial opacities and classified by severity on a scale from 0 to 3. Clinical factors (age, symptoms, comorbidities) were investigated for association with opacity severity and also with placement of central line or endotracheal tube. Deep learning models were then trained for two tasks: lung segmentation and opacity detection. Imaging characteristics were compared to clinical datapoints using the unpaired student's t-test or Mann-Whitney U test. Cohen's kappa analysis was used to evaluate the concordance of deep learning to conventional radiologist interpretation.

resultsFifty-six percent of patients presented with alveolar opacities, 73% had interstitial opacities, and 23% had normal X-rays. The presence of alveolar or interstitial opacities was statistically correlated with age (P = 0.008) and comorbidities (P = 0.005). The extent of alveolar or interstitial opacities on baseline X-ray was significantly associated with the presence of endotracheal tube (P = 0.0008 and P = 0.049) or central line (P = 0.003 and P = 0.007). In comparison to human interpretation, the deep learning model achieved a kappa concordance of 0.51 for alveolar opacities and 0.71 for interstitial opacities.

conclusionChest X-ray analysis in an acute COVID-19 outbreak showed that the severity of opacities was associated with advanced age, comorbidities, as well as acuity of care. Artificial intelligence tools based upon deep learning of COVID-19 chest X-rays are feasible in the acute outbreak setting.

Indexed as

AdultAgedAge FactorsComorbidityCOVID-19Deep LearningFeasibility StudiesFemaleHumansItalyMaleMiddle AgedRadiography, ThoracicRadiologistsRetrospective StudiesSARS-CoV-2

Identifiers

PMID32815519
PMCPMC7837735
OpenAlexW3048407206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.